Home・Aktien・Certara Inc

Certara Inc

Geschlossen

BrancheGesundheitswesen

8.27 -0.96

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

8.01

Max

8.35

Schlüsselkennzahlen
By Trading Economics
Einkommen	-380K -9.1M
Verkäufe	-14M 93M
KGV Branchendurchschnitt	100.714 57.366
EPS	0.05
Gewinnspanne	-9.803
Angestellte	1,515
EBITDA	-4.2M 12M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.23% downside

Dividenden
By Acuity
Nächstes Ergebnis	5. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-58M 1.2B
Vorheriger Eröffnungskurs	9.23
Vorheriger Schlusskurs	8.27

Nachrichtenstimmung

By Acuity

50%

120 / 340 Ranking in Healthcare

Certara Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Aug. 2026, 20:01 UTC

Certara Inc shares are higher today, continuing an upward trend since Wednesday. Broader market sentiment may be influenced by declining initial jobless claims.

26. Aug. 2026, 19:56 UTC

Shares of Certara Inc. are modestly higher today, reflecting typical intraday fluctuations. No specific company news was identified to explain the move.

25. Aug. 2026, 20:51 UTC

Certara Inc shares are higher in after-market trading, continuing a rise since Tuesday's close amid favorable market conditions and lower U.S. Treasury yields.

24. Aug. 2026, 20:01 UTC

Certara Inc shares are lower today, continuing a decline since Friday's close amid broader market pressures and geopolitical concerns affecting oil supply and inflation.

21. Aug. 2026, 19:56 UTC

Certara Inc shares are lower today, continuing a decline since Thursday. The stock is significantly below its 20-day moving average.

20. Aug. 2026, 20:06 UTC

Certara Inc shares are higher during Thursday's session, reflecting broader market dynamics and notable increases in U.S. Treasury yields and crude oil prices.

19. Aug. 2026, 23:56 UTC

Certara Inc. shares are lower in after-hours trading, showing slight declines since Wednesday's close while remaining above the 20-day moving average.

18. Aug. 2026, 19:36 UTC

Certara Inc. is trading higher during Tuesday's session, maintaining routine performance within a narrow range above its 20-day moving average.

13. Aug. 2026, 19:41 UTC

Certara Inc is rising, supported by strength in the Health Care Technology sub-sector, despite a slight pullback from earlier session highs.

12. Aug. 2026, 19:46 UTC

News

Certara shares are lower as Jefferies raises the price target to $7.45 from $6.00 while maintaining a Hold rating.

11. Aug. 2026, 23:51 UTC

Certara Inc is higher in after-hours trading, reflecting strong momentum and robust interest following notable activity earlier in the session.

7. Aug. 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6. Aug. 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5. Aug. 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4. Aug. 2026, 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3. Aug. 2026, 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31. Juli 2026, 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30. Juli 2026, 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29. Juli 2026, 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

28. Juli 2026, 18:36 UTC

Certara Inc is higher during Tuesday's session, continuing gains from Monday. The stock remains above its 20-day moving average despite an intraday pullback.

27. Juli 2026, 19:07 UTC

Certara Inc shares are trading higher during Monday's session, reflecting positive momentum since Friday's close, despite no specific company news identified.

24. Juli 2026, 18:02 UTC

Certara Inc shares are trading higher today, continuing gains since Thursday's close. No specific news was identified to explain the upward movement.

23. Juli 2026, 20:06 UTC

Shares of Certara Inc are higher during Thursday's session, continuing a notable increase since Wednesday's close. No specific news was identified for this movement.

22. Juli 2026, 20:04 UTC

Certara Inc's shares are higher during Wednesday's session, recovering from an early decline amid broader market uncertainty ahead of the Federal Reserve meeting.

20. Juli 2026, 19:31 UTC

News

Certara Inc partners with NVIDIA to enhance its AI biosimulation platform. Shares are higher, reflecting positive market sentiment around the collaboration.

Peer-Vergleich

Kursveränderung

Certara Inc Prognose

Kursziel

By TipRanks

-3.23% Nachteil

12-Monats-Prognose

Durchschnitt 8.08 USD -3.23%

Hoch 9 USD

Tief 7 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Certara Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

8 ratings

Buy

Halten

Sell

Basierend auf 8 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Certara Inc – Dist abgegeben haben.

Stimmung

By Acuity

120 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.